CD274 and lung carcinoma: Gao’s research (Guo et al., 2020) in lung cancer has revealed that inhibiting PI3K can downregulate PD-L1 expression and enhance the antiproliferative effects of IFN-γ, indicating that blocking PI3K can maximize the antitumor effects mediated by IFN-γ.